Introduction Ticagrelor, sold under the brand name Brilinta, is an oral antiplatelet medication used to prevent blood clots and reduce the risk of heart attack or stroke in people with acute coronary syndrome or a history of myocardial infarction. Ticagrelor selectively and reversibly binds to the adenosine diphosphate (ADP) receptor P2Y12 on platelets, minimally inhibiting ADP-induced platelet...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian